Sight Sciences, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +1.8%
EBITDA: +27.7%
EBIT: +28.2%
EPS: +27.7%
Free cash flow: -3.9%
Operating cash flow: -3.9%

Forward estimates

Revenue: +13.9%
EBITDA: —
EPS: +30.6%

Three-year CAGR

Revenue: +2.7%
EBITDA: +28.6%
EBIT: +26.6%
Net income: +25.4%
EPS: +28.2%
Free cash flow: -31.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.